Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’ - Edward Fanelli, 57, shared his regrets about taking Ozempic after he was diagnosed ...

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

Oscar Mayer’s iconic Wienermobile fleet will be “hot dogging” it later this week at the inaugural "Wienie 500.” The six ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” first quarter ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Analysts forecast explosive growth ahead for AI in healthcare, with MarketsandMarkets projecting the market to surge past $110 billion by 2030 on a 38.6% compound annual growth rate. Accenture goes ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

Some doubt has been cast on the future of pharma firm Novo Nordisk after its ousting... The FTSE 100 opened in the green on Tuesday as shares in Diploma Plc climbed 15 per... US drugmaker Pfizer said ...

Xeinadin, the professional services firm, has announced the acquisition of KBG Accountants... DUBLIN The Iseq All Share opened in the green, rising 0.29 per cent (+32.68bps) since... The operator of ...